Lista de obras - Laurence Gladieff - Dominio Público Uruguay

A comparative study of laparoscopic extraperitoneal lymphadenectomy [correction of laparoscopy] with the use of ultrasonically activated shears

artículo científico publicado en 2009

A phase I study of ixabepilone in combination with epirubicin in patients with metastatic breast cancer

scientific article published on 01 June 2012

A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.

artículo científico publicado en 2009

Adherence to guidelines in gynecologic cancer surgery.

artículo científico publicado en 2014

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis

artículo científico publicado en 2012

Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers

artículo científico publicado en 2015

CXCL12 expression by healthy and malignant ovarian epithelial cells.

artículo científico publicado en 2011

Cancers de l’ovaire BRCA muté : consultation d’oncogénétique et prescription des inhibiteurs de PARP.

artículo científico publicado en 2017

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.

artículo científico publicado en 2011

Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer ⬇️

artículo científico publicado el 3 de febrero de 2011

Childhood anaplastic large cell lymphoma Ki-1/CD30: clinicopathologic features of 19 cases.

artículo científico publicado en 1994

Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer

artículo científico publicado en 2013

Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers

artículo científico publicado en 2017

Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure

artículo científico publicado en 2010

Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing

article

French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing

artículo científico publicado en 2012

GENESIS: a French national resource to study the missing heritability of breast cancer

artículo científico publicado en 2016

Gene and pathway level analyses of iCOGS variants highlight novel signalling pathways underlying familial breast cancer susceptibility

artículo científico publicado en 2020

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

artículo científico publicado en 2014

Intraperitoneal chemotherapy in the treatment of advanced ovarian cancer

artículo científico publicado en 2010

Laparoscopic management of an isolated ovarian metastasis on a transposed ovary in a patient treated for stage IB1 adenocarcinoma of the cervix

scientific article published on 01 January 2009

Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

artículo científico publicado en 2008

Model-based approach to describe G-CSF effects in carboplatin-treated cancer patients.

artículo científico publicado en 2013

Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.

artículo científico publicado en 2018

Pelvic lymph node dissection via a lateral extraperitoneal approach: description of a technique

artículo científico publicado en 2008

Peritoneal pseudomyxoma arising from the urachus.

scientific article published on 26 February 2010

Phase I study of irinotecan and cisplatin in combination with pelvic radiotherapy in the treatment of locally advanced cervical cancer: A GINECO trial

artículo científico publicado en 2010

Pitfalls of CA-125 levels in the preoperative work-up of ovarian masses

artículo científico publicado en 2008

Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive su

artículo científico publicado en 2014

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study

scientific article published on 01 April 2006

Prognostic relevance of celiac lymph node involvement in ovarian cancer.

artículo científico publicado en 2014

Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG).

artículo científico publicado en 2013

Spontaneous regression of peritoneal carcinomatosis in a borderline ovarian tumour

artículo científico publicado en 2008

Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families

artículo científico publicado en 2017

The contribution of germline rearrangements to the spectrum of BRCA2 mutations

artículo científico publicado en 2006

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

artículo científico publicado en 2010

Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer)

artículo científico publicado en 2014

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

artículo científico

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

artículo científico publicado en 2012

Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)

artículo científico publicado en 2011

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GI

artículo científico publicado en 2011

Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?

artículo científico publicado en 2013

[Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer]

artículo científico publicado en 2009

[Pharmacological bases of intraperitoneal chemotherapy]

artículo científico publicado en 2009

[Preservation of fertility in gynaecologic cancers]

artículo científico publicado en 2008

[Towards a new standard in cytoreductive surgery for advanced ovarian cancer]

scientific article published on 01 December 2009

Lista de obras de Laurence Gladieff

A comparative study of laparoscopic extraperitoneal lymphadenectomy [correction of laparoscopy] with the use of ultrasonically activated shears

A phase I study of ixabepilone in combination with epirubicin in patients with metastatic breast cancer

A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.

Adherence to guidelines in gynecologic cancer surgery.

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis

Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers

CXCL12 expression by healthy and malignant ovarian epithelial cells.

Cancers de l’ovaire BRCA muté : consultation d’oncogénétique et prescription des inhibiteurs de PARP.

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.

Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer ⬇️

Childhood anaplastic large cell lymphoma Ki-1/CD30: clinicopathologic features of 19 cases.

Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer

Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers

Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure

Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing

French women's breast self-examination practices with time after undergoing BRCA1/2 genetic testing

GENESIS: a French national resource to study the missing heritability of breast cancer

Gene and pathway level analyses of iCOGS variants highlight novel signalling pathways underlying familial breast cancer susceptibility

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

Intraperitoneal chemotherapy in the treatment of advanced ovarian cancer

Laparoscopic management of an isolated ovarian metastasis on a transposed ovary in a patient treated for stage IB1 adenocarcinoma of the cervix

Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

Model-based approach to describe G-CSF effects in carboplatin-treated cancer patients.

Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.

Pelvic lymph node dissection via a lateral extraperitoneal approach: description of a technique

Peritoneal pseudomyxoma arising from the urachus.

Phase I study of irinotecan and cisplatin in combination with pelvic radiotherapy in the treatment of locally advanced cervical cancer: A GINECO trial

Pitfalls of CA-125 levels in the preoperative work-up of ovarian masses

Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive su

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study

Prognostic relevance of celiac lymph node involvement in ovarian cancer.

Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG).

Spontaneous regression of peritoneal carcinomatosis in a borderline ovarian tumour

Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families

The contribution of germline rearrangements to the spectrum of BRCA2 mutations

Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics

Updated results from OCTAVIA (front-line bevacizumab, carboplatin and weekly paclitaxel therapy for ovarian cancer)

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GI

Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?

[Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer]

[Pharmacological bases of intraperitoneal chemotherapy]

[Preservation of fertility in gynaecologic cancers]

[Towards a new standard in cytoreductive surgery for advanced ovarian cancer]